Vertex Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for povetacicept, an investigational treatment for adults with immunoglobulin A nephropathy (IgAN).

Pfizer and Innovent Biologics have entered into a global strategic licensing and collaboration agreement to support the research and development of 12 early-stage cancer medicines. The partnership covers antibody-drug conjugates

Nanoscope Therapeutics has selected McKesson’s InspiroGene platform to support the US commercialisation of its lead retinal therapy candidate, MOGENRY™, subject to regulatory approval in the country.

Insilico Medicine and Human Longevity have announced a multi-million-dollar collaboration to co-develop what the companies describe as the industry’s first large-scale artificial intelligence (AI) foundation model focused on human longevity science.

Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy Claude Enterprise across its global operations.

MEKanistic Therapeutics has received clearance from the U.S. Food and Drug Administration for its Investigational New Drug (IND) application for MTX-531, allowing the company to begin a Phase 1 clinical trial in advanced solid tumours.

Bio-Thera Solutions and Accord BioPharma have announced that the US Food and Drug Administration (FDA) has approved IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi), the first biosimilars to Simponi® and Simponi Aria® in the United States.

INmune Bio Inc. has announced that the U.S. Food and Drug Administration has granted Fast Track designation to XPro™ (pegipanermin) for the treatment of early Alzheimer’s disease.

Elabscience has launched a self-developed PolyHRP-Streptavidin conjugate designed to improve the sensitivity of enzyme-linked immunosorbent assay (ELISA) testing for low-abundance biomarker detection.

Samsung Bioepis and ATLATL have signed a Memorandum of Understanding to drive early-stage biotechnology innovation across the Asia-Pacific region, focusing on R&D collaboration.